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Cyclins are regulatory subunits of cyclin-dependent
kinases. Cyclin A, the first cyclin ever cloned, is
thought to be an essential component of the cell-
cycle engine. Mammalian cells encode two A-type
cyclins, testis-specific cyclin A1 and ubiquitously
expressed cyclin A2. Here, we tested the requirement
for cyclin A function using conditional knockout mice
lackingbothA-typecyclins.We found that acuteabla-
tion of cyclin A in fibroblasts did not affect cell prolif-
eration, but led to prolonged expression of another
cyclin, cyclin E, across the cell cycle. However,
combined ablation of all A- and E-type cyclins extin-
guished cell division. In contrast, cyclin A function
was essential for cell-cycle progression of hemato-
poietic and embryonic stem cells. Expression of
cyclin A is particularly high in these compartments,
which might render stem cells dependent on cyclin
A, whereas in fibroblasts cyclins A and E play redun-
dant roles in cell proliferation.
INTRODUCTION
Replication of genetic material during cell division in Metazoan
organisms is thought to be driven by cyclin A. Cyclin A was the
first cyclin cloned in any organism (Swenson et al., 1986). It
was originally described as a protein with periodic expression
pattern in clam embryos (Evans et al., 1983). Subsequently,
cyclin A genes have been found in all multicellular organisms,
including humans (Pines and Hunter, 1990). While only a single
cyclin A gene is present in the genomes of C. elegans and
Drosophila, mammalian cells express two A-type cyclins, A1
and A2 (Nieduszynski et al., 2002). Cyclin A1 is expressed almost352 Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc.exclusively in the testes and during meiosis in the male germline
(Sweeney et al., 1996; Yang et al., 1997), and male knockout
mice lacking cyclin A1 are sterile because of an arrest in meiotic
prophase at the diplotene stage, just before the first meiotic divi-
sion (Liu et al., 1998; van der Meer et al., 2004). The second
mammalian A-type cyclin, cyclin A2, is ubiquitously expressed
in all proliferating cells and is generally considered to be the
mammalian S phase cyclin (Hochegger et al., 2008; Pines and
Hunter, 1990; Yam et al., 2002). During cell-cycle progression,
cyclin A2 is induced at the beginning of the S phase (Erlandsson
et al., 2000; Girard et al., 1991). Once induced, cyclin A2 binds
and activates its catalytic partners, cyclin-dependent kinases
Cdk2 and Cdk1. These cyclin A2-Cdk complexes phosphorylate
critical proteins that play role in DNA synthesis, thereby driving
S phase progression (Yam et al., 2002). Cyclin A2 is expressed
throughout the S and G2 phases, and is rapidly degraded upon
entry of cells intomitosis (Geley et al., 2001; den Elzen and Pines,
2001). Injection of anti-cyclin A2 antibodies or antisense con-
structs into in vitro-cultured fibroblasts or other cell types
blocked DNA synthesis, consistent with the essential function
for cyclin A in DNA replication (Girard et al., 1991; Pagano
et al., 1992; Zindy et al., 1992). In addition, cyclin A2 was postu-
lated to play a role in entry of cells into mitosis (Swenson et al.,
1986), and injection of anti-cyclin A2 antibodies into in vitro-
cultured fibroblasts, or inhibition of cyclin A2 function by
p21Cip1 during the G2 phase, blocked G2/Mphase progression
(Furuno et al., 1999; Pagano et al., 1992). An essential function
for cyclin A in cell proliferation is supported by the observations
that cyclin A2 knockout mouse embryos died shortly after
implantation (Murphy et al., 1997). These studies have led to
the current model that the ‘‘core’’ components of the cell-cycle
machinery (cyclins A and B) represent absolutely integral
elements of the cell-cycle engine (Hochegger et al., 2008;
Murphy et al., 1997). In the work described below, we decided
to revisit the requirement for cyclin A function in cell proliferation
using conditional cyclin A knockout mice.
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Figure 1. Generation of cyclin A2f/f Mice
(A) cyclin A2 gene targeting strategy. Coding exons are shown as filled boxes and are numbered. Neo, neomycin phosphotransferase gene. loxP and FRT
sequences are indicated, as light blue triangles and dark blue rectangles, respectively. Restriction enzyme recognition sites: K, KpnI; Sb, SnaBI; X, XbaI; N,
NdeI; Sp, SphI; Sl, SalI; S, SmaI. Solid black lines represent Southern blotting probes A and B used to screen for homologous recombination. Arrows denote
PCR primers used for genotyping animals (p1, p2, p4,) or for nested PCR (1M, 2M, 2L, 4L). Also shown is the conditional cyclin A2flox locus and the deleted cyclin
A2D allele after Cre-mediated recombination.
(B) Southern blot analysis of genomic DNA extracted from wild-type (WT) and A2f/+ ESC clones. DNA was digested with KpnI and SphI and hybridized with probe
A (50 end screening) or digested with NdeI and hybridized with probe B (30 end screening). The sizes of WT and ‘‘floxed’’ alleles are shown.
(C) Expected and observed frequency of E7.5 embryos obtained in cyclin A2D/+ 3 A2D/+ cross.
(D) Western blot analysis of cyclin A2 in wild-type mouse embryo fibroblasts (WT), A2f/f cells, A2f/f cells transduced with a retrovirus expressing an inactive, point
mutant version of Cre (A2f/f +control), Af/f cells transduced with Cre-expressing virus (A2D/D), or A1/A2f/f cells transduced with Cre (A1/A2D/D).RESULTS
Generation and Characterization of Conditional
Cyclin A2 Knockout Mice
To obtain a conditional cyclin A2 allele, we inserted loxP sites into
the first and seventh intron of the murine cyclin A2 gene
(Figure 1A). The gene-targeting construct was introduced
into embryonic stem cells (ESCs), and heterozygous cyclin A2f/+
(Af denotes the ‘‘floxed’’ allele) ESCs were obtained through
homologous recombination (Figures 1A and 1B). cyclin A2f/+
ESCs were then injected into mouse blastocysts, and homozy-
gous cyclin A2f/f animals were generated via standard proce-
dures (Geng et al., 2003). cyclinA2f/fmicewere viable andpheno-
typically normal (datanot shown), consistentwithour expectation
that the ‘‘floxed’’ cyclin A2 allele is functionally wild-type.
In order to verify that deletion of the ‘‘floxed’’ cyclin A2
sequences resulted in a functionally null allele, we crossed cyclin
A2f/f mice with a ‘‘deleter’’ Meox2-Cre strain (Tallquist and Sor-
iano, 2000) and generated cyclin A2D/+ mice (A2D denotes the
deleted cyclin A2 allele). We then intercrossed cyclin A2D/+heterozygotes, sacrificed pregnant females 7 days post coitum,
and genotyped the embryos. No cyclin A2D/D embryos were
observed (Figure 1C), consistent with the early embryonic
lethality associated with a cyclin A null phenotype. Hence, dele-
tion of the ‘‘floxed’’ cyclin A2 sequences converts the conditional
cyclin A2 allele into a functionally null allele.
Analyses of cyclin A Null Fibroblasts
We next derived fibroblasts from conditional cyclin A2 knockout
embryos and cultured them in vitro. Transduction of cyclin A2f/f
cells with Cre-expressing retroviruses led to essentially
complete loss of cyclin A2 protein (Figure 1D). Very unexpect-
edly, we found that an acute ablation of cyclin A2 had no major
impact on cell proliferation. Thus, cyclin A2D/D cells normally
increased cell number during in vitro culture (Figure 2A), and nor-
mally re-entered the cell cycle from quiescence (Figure 2B).
However, analyses of cell-cycle progression with propidium
iodide and anti-BrdU staining revealed that ablation of cyclin
A2 increased the fraction of cells in S and G2/M phases, with
concomitant decrease in the G1 population (Figures 2C and 2D).Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc. 353
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Figure 2. Analyses of cyclin A2D/D and A1/A2D/D
Fibroblasts
(A) In vitro proliferation of fibroblasts transduced with
control virus (+control) or with Cre-expressing retrovirus
(A2D/D and A1/A2D/D). Equal numbers of cells were
plated at the beginning of the experiment. Cells were
counted every day for 7 days.
(B) Cell-cycle re-entry analysis. Cells transduced as above
were rendered quiescent by serum deprivation and then
stimulated to re-enter the cell cycle by addition of serum.
Entry into S phase was gauged by measurement of [3H]-
thymidine uptake.
(C) Cell-cycle distribution of asynchronously growing
mouse embryonic fibroblasts cultured in vitro. Cells were
transduced as above, pulsed with bromodeoxyuridine
(BrdU) for 1 hr, and then stained with anti-BrdU antibodies
and with propidium iodide followed by fluorescence-
activated cell sorting (FACS) analysis. The percentages
of cells in particular phases of cell cycle are shown.
(D) Histogram representation of the data shown in (C). For
each genotype, we analyzed four independent fibroblast
cultures, prepared from four different embryos. Shown
are mean values ± SD. The significance of differences
was analyzed by the t test.354 Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc.
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Figure 3. Molecular Analyses of cyclin A1/A2D/D Fibroblasts
(A) The levels of cell-cycle regulators in cyclin A-deficient fibroblasts. Lysates were prepared from cyclin A1/A2f/f fibroblasts transducedwith control (Control) or
Cre-encoding viruses (A1/A2D/D), immunoblotted, and probed with the indicated antibodies.
(B) Similar analysis as in (A) with A2D/D and A1/A2D/D cells.
(C) Cdk1 and Cdk2 were immunoprecipitated from lysates prepared as above and subjected to in vitro kinase reactions with histone H1 as a substrate.
(D) Levels of cell-cycle regulators during cell-cycle progression. Cells were arrested in G0 by serum deprivation and stimulated to re-enter the cell cycle by
addition of serum. Cells were collected at the indicated time points after serum stimulation and analyzed by western blotting. The arrow indicates a band cor-
responding to cyclin D2.
(E) Quantification of cyclin E1 and A2 levels at different time-points during re-entry into the cell cycle.Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc. 355
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Figure 4. Analyses of Fibroblasts Lacking All A- and E-Type Cyclins
(A) Diagram illustrating generation of quadruple-knockout fibroblasts via tetraploid complementation. The right-hand panel shows western blot analysis of cyclin
A2 levels in cyclin A1/A2f/fE1/E2/ cells transduced with adenovirus encoding empty vector (Control) or Cre (A1/A2D/DE1/E2/).
(B and C) Incorporation of [3H]-thymidine (B) and the percentage of BrdU-positive cells (C) in cyclin A1/A2f/fE1/E2/ fibroblasts transduced as above. Shown
are mean values ± SD.356 Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc.
To rule out the possible contribution from cyclin A1, we
crossed cyclin A2f/f mice with cyclin A1 null animals (Liu et al.,
1998; Ji et al., 2005) and generated cyclin A1/A2f/fmice. Fibro-
blasts were isolated from cyclin A1/A2f/f embryos, cultured
in vitro, and transduced with Cre-expressing viruses, thereby
ablating all cyclin A expression (Figure 1D, and Figure S1A avail-
able online). We found that cells lacking all A-type cyclins prolif-
erated normally in culture (Figure 2A) and entered the S phase
from G0 without any delay (Figure 2B). Again, analyses of the
cell-cycle profile revealed increased fraction of cells in S and
G2/M phases with concomitant decrease in the G1 population
(Figures 2C and 2D), similar to that seen in cyclin A2D/D cells.
To further investigate these cell-cycle alterations, we com-
pared the length of G1, S, and G2/M phases in control versus
in cyclin A1/A2D/D mouse embryonic fibroblasts (MEFs) using
pulse-chase experiments. Specifically, we pulsed in vitro-
cultured MEFs with BrdU and followed the progression of
BrdU-labeled cells through S, G2/M, and G1 phases (see the
Supplemental Experimental Procedures). We found that ablation
of cyclin A resulted in increased length of the S phase (from
approximately 7 hr in control to approximately 8 hr in cyclin
A1/A2D/D) and also prolonged the G2/M phases (from 5 to
6 hr). In contrast, the length of G1 phase was approximately
1.5 hr shorter upon cyclin A2 ablation. These analyses are
consistent with the increased fraction of cyclin A1/A2D/D cells
in S and G2/M phases and decreased percentage in G1 (Figures
2C and 2D), as well as with overall normal cell division time in
cyclin A null cells (Figure 2A).
To elucidate the molecular basis of cell division in the absence
of A cyclins, we first compared the expression of various cell-
cycle proteins between control versus cyclin A null (A1/A2D/D)
cells. We found that the levels of cyclins D1, D2, B, Cdk1,
Cdk2, Cdk4, Cdk6, and p27Kip1, as well as Cdk2-associated
kinase activity, were essentially unchanged in cyclin A null fibro-
blasts, while the activity of Cdk1 kinase wasmodestly decreased
(Figures 3A and 3C). In contrast, we found that cyclin E was
markedly upregulated after acute cyclin A shutdown (Figures
3A and 3B).
We also analyzed the expression levels of cyclins and Cdks
across cell-cycle progression. In control cells, cyclin E levels
peaked in early S phase, and declined thereafter, when most
cells were traversing the S phase (Figures 3D and 3E). In cyclin
A null cells, however, cyclin E assumed a broad cell-cycle
expression pattern resembling the combined expression of
cyclins E plus A in wild-type cells (Figure 3E). On the other
hand, the pattern of cyclin D1, D2, and D3 expression was com-
parable between control and mutant cells (Figure 3D and data
not shown). We therefore hypothesized that cyclin E was respon-
sible for the relatively normal proliferation of cyclin A null cells.
To extend these findings, we analyzed phosphorylation status
of a panel of cyclin A-Cdk and E-Cdk substrates in cyclin A-defi-cient cells, using phospho-specific antibodies. We observed
essentially unperturbed phosphorylation of these proteins in
cyclin A1/A2D/D MEFs (Figure S2A). We also verified normal
levels of several E2F target genes in cyclin A null cells (Fig-
ure S2B), indicating that phosphorylation and concommittant
functional inactivation of the retinoblastoma protein and other
‘‘pocket’’ proteins by Cdk-containing complexes proceeded
normally in the absence of cyclin A. These findings were consis-
tent with the possibility that cyclin E-Cdk complexes might
perform cyclin A-Cdk functions in cyclin A null MEFs.
Generation and Analyses of Cells Lacking
All A-Type and E-Type Cyclins
To rigorously test this possibility, we decided to combine abla-
tion of A-type and E-type cyclins and to generate cells lacking
all these proteins. Of note, mammalian cells express two
E-type cyclins, E1 and E2 (Sherr and Roberts, 2004). Ablation
of both E cyclins in mice led to embryonic lethality at day 10.75
of gestation because of placental abnormalities (Geng et al.,
2003; Parisi et al., 2003). In order to obtain cyclin E null fibro-
blasts, we previously turned to the tetraploid blastocyst comple-
mentation rescue method, which essentially provided cyclin
E null embryos with wild-type (tetraploid) placentas (Geng
et al., 2003). Using this method, we bypassed the placental
failure and obtained day 13.5 cyclin E1/E2/ embryos, from
which in vitro cultures of embryonic fibroblasts were derived.
cyclin E1/E2/ fibroblasts proliferated relatively normally
during conditions of continuous cell growth, but they were
unable to re-enter the cell cycle from quiescence. These cyclin
E null cells expressed normal levels of cyclin A2, and had normal
cyclin A2-associated kinase activity (Geng et al., 2003).
In order to obtain quadruple-knockout cyclin E- and A-defi-
cient embryos andfibroblasts,weagain utilized tetraploid blasto-
cyst complementation method. Specifically, we interbred cyclin
A1/,A2f/f, E1/, and E2/ animals and generated compound
heterozygotes (Figure 4A). We next intercrossed these animals,
sacrificed females at day 3.5 post coitum, and derived ESCs
from blastocyst-stage cyclin A1/A2f/fE1/E2/ embryos.
We next injected cyclin A1/A2f/fE1/E2/ ESCs into tetra-
ploid wild-type blastocysts and implanted them into foster
females for further development (Figure 4A). Since the tetraploid
cells can contribute only to the extraembryonic tissues (Eggan
et al., 2001), in the resulting chimeric embryos the embryo proper
wasderivedentirely fromthe injectedcyclinA1/A2f/fE1/E2/
ESCs, while the placentas were ‘‘wild-type’’ (tetraploid). We
sacrificed embryos at day 13.5 of gestation, derived in vitro
cultures of cyclin A1/A2f/fE1/E2/ fibroblasts, and trans-
duced these cells with viruses expressing Cre recombinase,
thereby deleting cyclin A2 and rendering the cells null for all
A- and E-type cyclins (Figures 4A, S1B, and S3). Strikingly,
combined ablation of cyclins A and E essentially extinguished(D) Upper panel: fibroblasts, cultured in medium containing 10% serum, were stained with propidium iodide and analyzed by FACS. Lower panel: cells were
placed in serum-free medium for 3 days, stained with propidium iodide, and analyzed by FACS.
(E) In vitro proliferation of fibroblasts. Equal numbers of cells were plated at the beginning of the experiment. Cells were counted every day for 7 days. This exper-
iment was performedwith cells immortalizedwith dominant-negative p53, as cyclin E-deficient cells undergo premature senescence in culture (Geng et al., 2003).
(F) The levels of the indicated proteins in cyclin A- and E-deficient fibroblasts, detected by western blotting.
(G) Cyclin B1, Cdk1, or Cdk2 was immunoprecipitated from protein lysates and used for in vitro kinase reactions with histone H1 as a substrate.Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc. 357
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Figure 5. Impact of Cyclin A Ablation on Hematopoiesis
(A) Survival of control cyclin A1+/A2f/+ MxCre (Mx Control), A2f/f MxCre (Mx A2D/D), and A1/A2f/f MxCre (Mx A1/A2D/D) mice after five doses of pI-pC. Each
group consisted of 18 mice. Lower panel: deletion of cyclin A2 in bone marrow cells was verified by western blotting 7 days after the last pI-pC injection.
(B) Mean number of red blood cells (RBC), white blood cells (WBC), and platelets (PLT) in the peripheral blood of mice of the indicated genotypes (n = 6 per group)
after pI-pC administration.
(C) Mean number of bone marrow cells per two femurs. Lower panel: histological sections of bones with bone marrow were stained with hematoxylin and eosin.
Note acellular bone marrow in Mx A1/A2D/D animals.
(D)Mean number of Gr-1+ (granulocyte), Mac-1+ (macrophage), Ter119+ (erythroid), B220+ (B cells), andCD3+ (T cells) in the bonemarrow. Cells were stainedwith
respective antibodies, followed by FACS.358 Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc.
cell proliferation (Figure 4E) and crippled incorporation of [3H]-
thymidine and BrdU (Figures 4B, 4C, and S4), indicating an
inability of cells to synthesize DNA. This, together with relatively
normal S phase progression of cyclin E null (E1/E2/) (Geng
et al., 2003; Parisi et al., 2003) and cyclin A null (A1/A2D/D) cells
(Figure 2), reveals that either cyclin E or cyclin A must be present
to allow DNA synthesis.
Surprisingly, staining of growth-arrested cyclin A1/A2D/D
E1/E2/ cells with propidium iodide revealed essentially
unchanged percentage of cells with 2NDNA content (‘‘G1’’), cells
containing between 2N and 4NDNA (‘‘S’’), and cells with 4NDNA
content (‘‘G2/M’’), as compared to actively proliferating cyclin
A1/A2f/f E1/E2/ cells (see Figure 4D, upper panel). The
unchanged fraction of cells containing between 2N and 4N
DNA, together with crippled thymidine and BrdU incorporation
(Figures 4B and 4C), indicates intra-S phase arrest in cyclin
A1/A2D/D E1/E2/ cells. Moreover, ablation of cyclin A in
quadruple-knockout MEFs led to retention of G2/M cells with
4N DNA (in the absence of cell division). This indicates that in
addition to the S phase block, cyclin A- and E-deficient cells
arrest in G2/M, which is consistent with the proposed function
of cyclin A not only in the S phase, but also during G2/M tran-
sition (Swenson et al., 1986; Furuno et al., 1999; Gong et al.,
2007; Pagano et al., 1992).
We also performed additional experiments to confirm that
cyclin A1/A2D/D E1/E2/MEFs are ‘‘locked’’ in S and G2/M
phases. Thus, we placed proliferating cyclin A1/A2f/fE1/
E2/ cells and nonproliferating cyclin A1/A2D/D E1/E2/
cells in serum-free medium, and we analyzed their cell-cycle
distribution by propidium iodide staining. As expected, upon
serum starvation, proliferating cyclin A1/A2f/fE1/E2/ cells
exited the cell cycle and arrested in G0/G1 (2N DNA), with
concomitant decrease in S and G2/M fractions. In contrast, the
DNA content of nonproliferating cyclin A1/A2D/D E1/E2/
cells remained unchanged in serum-free medium (Figure 4D,
lower panel). These observations further underscore that
cyclin A1/A2D/D E1/E2/ cells are ‘‘locked’’ in S and G2/M
phases.
Molecular analyses of cyclin A1/A2D/D E1/E2/ cells re-
vealed that the levels of cyclin B and Cdk1 were greatly
decreased upon the loss of all A and E cyclins (Figure 4F).
Also, the levels of Cdk1-, Cdk2- and cyclin B-associated kinase
were profoundly diminished upon cyclin A/E ablation (Figure 4G).
These results are consistent the notion that cyclins A and E
represent the redundant activators of Cdk1 and Cdk2. Whereas
deletion of either A-type or E-type cyclins did notmarkedly affect
Cdk1/2 catalytic activity (Figure 3C) (Geng et al., 2003), the
combined ablation of all A and E cyclins extinguished Cdk1
and Cdk2 kinase and arrested S and G2/M phase progression.Requirement for Cyclin A Function in Hematopoietic
Stem Cells
Our observations that cyclin A function is dispensable for prolif-
eration of fibroblasts prompted us to study the requirement for
cyclin A in other cell types. We decided to focus on bonemarrow
cells, which contain several different hematopoietic lineages. To
avoid ambiguity in interpreting the results, we chose to ablate the
expression of all A-type cyclins, by combining our conditional
cyclin A2 knockout strain with cyclin A1/ animals. Thus, we
interbred cyclin A2f/f, A1/, and MxCre mice and generated
cyclin A1/A2f/f MxCre animals. The MxCre strain expresses
interferon-inducible Cre recombinase. Administration of double-
stranded RNA polyI-polyC (pI-pC) to MxCre mice induces inter-
feron, leading to activation of Cre, and results in a very efficient
ablation of the ‘‘floxed’’ sequences in bone marrow cells,
including in nearly 100% of hematopoietic stem cells (Kuhn
et al., 1995).
Administration of pI-pC to cyclin A1/A2f/f MxCremice extin-
guished cyclin A expression in the bone marrow and resulted in
death of the majority of animals within 30 days (Figure 5A). In
peripheral blood, we observed substantially decreased numbers
of red blood cells and white blood cells, as well as platelets
(Figure 5B), pointing to a severe anemia as a most likely cause
of death. Analyses of bone marrow revealed greatly reduced
numbers of bone marrow cells, with all lineages being equally
affected (Figures 5C–5E).
Since inMxCremice the deletion of the ‘‘floxed’’ sequences is
not confined to bone marrow, we used bone marrow transplan-
tation assays (Park et al., 2003) to ascertain that the observed
phenotype was intrinsic to hematopoietic cells. To this end,
we collected bone marrow cells from cyclin A1/A2f/f MxCre
mice (never exposed to pI-pC), mixed them at 1:1 ratio with
bone marrow cells derived from wild-type mice, and injected
the cells into irradiated wild-type recipients. In this procedure,
the injected hematopoietic stem cells reconstitute the bone
marrow of recipient animals, which now represents a 1:1
mixture of cyclin A1/A2f/f MxCre and wild-type cells, while
all other tissues of the recipient mouse are wild-type. Impor-
tantly, cyclin A1/A2f/f MxCre hematopoietic cells express
a different haplotype of the Ly surface antigen (Ly5.2) than do
wild-type cells (Ly5.1), thereby allowing their unequivocal identi-
fication (Park et al., 2003). After bone marrow reconstitution, we
injected recipient mice with pI-pC, resulting in deletion of cyclin
A selectively in Ly.5.2+ bone marrow hematopoietic cells. We
found that deletion of cyclin A drastically reduced the numbers
of Ly5.2+ blood cells (Figure 5F). At the end of observation period,
we sacrificed the mice, collected their bone marrow, and deter-
mined that Ly5.2+ cells contributed to only5% of bone marrow
cells. Flow sorting of these residual Ly5.2+ bone marrow cells(E) Mean number of myeloid colonies in methylcellulose cultures. Twenty thousand bone marrow cells were isolated from mice (n = 3 per group) 3 days after the
last administration of pI-pC (a total of three doses) and plated in duplicate. Colonies were counted after 12 to 14 days.
(F) A total of 2.53 106 Ly5.2+ bonemarrow cells from A1+/A2f/+ MxCre (Mx control) or A1/A2f/f MxCre (Mx A1/A2D/D) mice were adoptively transferred along
with 2.5 3 106 wild-type (Ly5.1+) bone marrow cells into lethally irradiated (1000 Rad) Ly5.1+ congenic recipients (n = 5 for each group) (BMT). After 6 weeks of
engraftment, chimeric mice were treatedwith five doses of pI-pC, and the percentage of peripheral blood cells expressing Ly5.2 was determined biweekly by flow
cytometry (shown are mean values for each time-point). Lower panel: at the end of experiment, genomic DNA was isolated from 5.2+ bone marrow cells and
analyzed by PCR for the presence of A2+, A2f, and A2D alleles.
Error bars represent the SD. In (A) and (F), ‘‘time 0’’ corresponds to the last day of pI-pC injection.Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc. 359
followed by PCR genotyping revealed that they arose from non-
deleted cyclin A1/A2f/D hematopoietic stem cells (Figure 5F).
Altogether, these analyses demonstrated that the requirement
for cyclin A function is intrinsic to hematopoietic cells.
To determine at which stage of hematopoiesis cyclin A func-
tion becomes first rate limiting, we collected bone marrow cells
7 days after cyclin A ablation and flow sorted hematopoietic
stem cells (HSCs), their descendants (lineage-committed
common myeloid progenitors, CMP, granulocyte-macrophage
progenitors, GMP, and megakaryocyte-erythroid progenitors,
MEP), as well as differentiated Mac-1+ (macrophage), Gr-1+
(granulocyte), and Ter119+ (erythroid) cells (Akashi et al., 2000;
Morrison et al., 1995). We found that ablation of cyclin A led to
a rapid disappearance of hematopoietic stem cells, as well as
of lineage-committed HSC descendants, CMP, GMP, and
MEP (Figures 6A and 6B). In contrast, the proportions of the
more differentiated Gr-1+, Mac-1+, and Ter-119+ cells were
unperturbed at this early time point (Figure 6C and not shown).
These analyses suggested that the primary defect after cyclin
A ablation was at the HSC and early progenitor stage.
To test this possibility further, we flow sorted hematopoietic
stem cells from cyclin A1/A2f/f mice and transduced them
with viruses encoding Cre and GFP. We again sorted GFP-posi-
tive HSCs and cultured them—one cell per well—in a cocktail of
cytokines that promotes HSC proliferation (Akashi et al., 2000).
As a control we used cyclin A1+/A2f/+ HSCs, which were sorted
and transduced in an identical fashion. As expected, Cre-trans-
duced cyclin A1+/A2f/+ HSCs proliferated in vitro and formed
colonies. PCR of individual colonies revealed that 29/31 of
them arose from cyclin A1+/A2D/+ HSCs, confirming that Cre
expression led to deletion of the ‘‘floxed’’ cyclin A2 alleles (Fig-
ures 7A and 7B). In contrast, Cre-transduced cyclin A1/A2f/f
HSCs failed to proliferate and never formed cyclin A1/A2D/D
colonies. We did observe a few colonies in Cre-transduced
cyclin A1/A2f/f HSCs; however, PCR analyses revealed they
all arose from the partially recombinedA1/A2f/DHSCs (Figures
7A and 7B). These results indicate that cyclin A is critically
required for proliferation of HSCs.
Requirement for Cyclin A Function in Embryonic
Stem Cells
These observations prompted us to analyze the requirement for
cyclin A function in another stem cell type, namely embryonic
stem cells. To ablate both A cyclins, we interbred cyclin A1/
and A2f/f animals, sacrificed pregnant females, collected blasto-
cyst-stage embryos, and derived cyclin A1/A2f/f as well as
control cyclin A1+/A2f/+ ESCs. We then transduced ESCs with
Cre-expressing retrovirus, plated out single cells, and allowed
them to form ESC colonies. The genotype of individual colonies
was determined by PCR. As expected, expression of Cre in
control cyclin A1+/A2f/+ ESCs converted them to A1+/A2D/+
cells, which then proliferated and formed A1+/A2D/+ ESC colo-
nies (78/92 analyzed, Figures 7C and 7D). In contrast, in case of
Cre-transduced cyclin A1/A2f/f ESCs, we observed 106 ESC
colonies derived from cells with one deleted cyclin A2 allele
(A1/A2f/D), but never detected any A1/A2D/D colonies (Fig-
ure 7C and 7D). Since it was formally possible that expression
levels of Cre in ESCs were sufficient to delete only one but not360 Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc.both ‘‘floxed’’ cyclin A2 alleles, we transduced cyclin A1/A2f/D
ESCs with Cre-expressing retrovirus. Out of 135 ESC colonies
analyzed, none arose from cyclin A1/A2D/D cells (Figure 7C).
These results indicate that deletion of both cyclin A2 alleles is
incompatible with ESC proliferation. Hence, as was the case in
hematopoietic stem cells, cyclin A is also required for prolifera-
tion of embryonic stem cells.
Molecular Analyses of Bone Marrow Cells
and Embryonic Stem Cells
Our analyses described above revealed that while in fibroblasts
cyclins E and A perform overlapping roles in cell-cycle progres-
sion, the proliferation of HSCs and ESCs critically depends on
cyclin A. To begin to elucidate themolecular basis of this require-
ment, we compared the levels of cyclins E and A between hema-
topoietic bone marrow cells versus fibroblasts.
Our analyses revealed that the levels of cyclin E in bone
marrow cells were dramatically lower than in fibroblasts. Even
at long exposure times we could barely detect cyclin E signal
in bonemarrow cells (Figure 7E). In contrast, the amount of cyclin
A2 in bone marrow cells was significantly higher than that in
fibroblasts (Figure 7E). Of note, in bone marrow samples cyclin
A2 migrates at approximately 38 kDa, unlike the 55 kDa isoform
seen in other compartments, as reported previously by Welm
et al. (2002) (Figures 7E and S5A). This shorter cyclin A2 isoform
was reported to lack N-terminal destruction box, but retained
Cdk binding and activation, and hence possibly represents
hyper-stable cyclin A species (Welm et al., 2002).
We also immunoprecipitated Cdk2 from bone marrow cells
and from fibroblasts and probed immunoblots with anti-cyclin
E and anti-cyclin A2 antibodies. Again, we observed paucity
of cyclin E-Cdk2 complexes in bone marrow cells, while cyclin
A-Cdk2 was more abundant in this compartment than in fibro-
blasts (Figure 7E). The overall levels of Cdk2-kinase activity
were comparable between the two compartments, while Cdk1-
associated kinase activity was markedly higher in bone marrow
cells than in MEFs (Figure 7F). Collectively, these observations
suggest that in hematopoietic cells, cyclin A represents the
major S phase cyclin, while cyclin E is expressed at very low
levels. Consequently, division of these cells critically depends
on cyclin A. In contrast, fibroblasts express both E- and A-type
cyclins, and each one of these cyclins is sufficient to drive normal
cell-cycle progression.
Our analyses of ESCs revealed that the levels of cyclin A2 in
these cells were substantially higher than those observed in
fibroblasts (Figure 7G). Immunoprecipitation of Cdk1 or Cdk2
followed by immunoblotting with anti-cyclin A2 antibodies indi-
cated that cyclin A2-Cdk1 and A2-Cdk2 complexes are substan-
tially more abundant in ESCs than in fibroblasts (Figures 7G and
S5B). We propose that in hematopoietic cells and ESCs, cyclin
A-CDK complexes greatly predominate over cyclin E-CDK
complexes, and this renders these cells dependent on cyclin A
for cell-cycle progression.
DISCUSSION
Cyclin A is considered an essential component of the cell-cycle
machinery. This notion is supported by the observations that
AB
C
Figure 6. Analyses of Hematopoietic Stem Cells and Progenitors
(A) Cells isolated from bone marrow of pI-pC-treated cyclin A1+/A2f/+ MxCre (Mx control), A2f/f MxCre (Mx A2D/D), and A1/A2f/f MxCre (Mx A1/A2D/D) mice
were stained for the presence of hematopoietic stem cells (HSC), common myeloid progenitors (CMP), granulocyte-macrophage progenitors (GMP), and
megakaryocyte-erythroid progenitors (MEP). The percentages of particular populations among all bone marrow cells are indicated.
(B) Total number of HSC, CMP, GMP and MEP calculated per two femurs in animals treated as above. Error bars represent the SD.
(C) Bone marrow cells from the same animals as in (B) were stained for the presence of more differentiated Gr-1+ and Mac-1+ cells.Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc. 361
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Figure 7. Analyses of Hematopoietic and Embryonic Stem Cells
(A) The numbers of resulting colonies of the indicated genotypes after transduction of in vitro-cultured control cyclin A1+/A2f/+ and cyclin A1/A2f/f HSCs
with Cre.
(B) Single-colony PCR of colonies derived from Cre-tranduced HSCs.
(C) The numbers of resulting colonies of the indicated genotypes after transduction of cyclin A1+/A2f/+, A1/A2f/f, and A1/A2f/D embryonic stem cells
with Cre.362 Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc.
Drosophila embryos arrested their proliferation as soon as
maternal cyclin A stores became depleted (Lehner and O’Farrell,
1989; 1990), while cyclin A2 knockout mice died shortly after
implantation (Murphy et al., 1997). In contrast, mice lacking
particular G1 cyclins or Cdks displayed normal proliferation in
the overwhelming majority of cell types and presented only
narrow, tissue-specific abnormalities (Sherr and Roberts, 2004;
Li et al., 2009; Malumbres and Barbacid, 2009). These observa-
tions led to the current model that there are essentially two types
of cyclin proteins: those that are vital components of the cell-
cycle engine (cyclins A and B), and those involved in cell type-
specific regulation of the cell cycle (G1 cyclins) (Hochegger
et al., 2008; Murphy et al., 1997).
In this study, we show that the early lethality of cyclin A null
embryos reflected the requirement for cyclin A function at this
particular stage of embryo development, rather than an ubiqui-
tous essential role for cyclin A in cell-cycle machinery. We
demonstrate that in fibroblasts—a cell type that has been
most extensively studied in the cell-cycle field—either cyclin
A or cyclin E is sufficient to drive S phase entry and progres-
sion, as well as entry of cells into the M phase. Cyclin A-Cdk
complexes are thought to phosphorylate distinct set of
proteins than cyclin E-Cdk kinase, and cyclin A-Cdk is
believed both to drive S phase progression and to prevent re-
replication of genetic material (Yam et al., 2002). However, our
analyses of the phosphorylation status of various Cdk1 and
Cdk2 substrates in cyclin A-deficient (A1/A2D/D) and E-defi-
cient (E1/E2/) MEFs revealed essentially unperturbed
phosphorylation of these proteins (Figure S2A). Moreover, we
found normal levels of E2F targets in cyclin A- and E-deficient
cells, indicating normal functional inactivation of the pocket
proteins (Figure S2B). Collectively, these analyses indicate
that cyclin A- and E-associated kinases can phosphorylate
the similar set of proteins in vivo, including proteins involved
in centrosome duplication (nucleophosmin), DNA replication
(Cdc6), transcription (B-Myb), and cell-cycle progression
(pocket proteins).
In contrast to the situation seen in fibroblasts, we found that
cyclin A function was essential for proliferation of hematopoietic
and embryonic stem cells. We found that in these two cell types,
cyclin A was expressed at particularly high levels, while cyclin E
was essentially absent in the hematopoietic lineage.We propose
that in the two stem cell types studied, cyclin A-Cdk complexes
greatly predominate over cyclin E-Cdk complexes, and this
renders these cells dependent on cyclin A for cell-cycle progres-
sion. The proliferation of several stem cell types was shown to be
driven by the Wnt-dependent pathways (Nusse, 2008), and it is
possible that these pathways impinge on the S phase machinery
by inducing cyclin A. In contrast, mitogenic signals operating in
fibroblasts may be capable of upregulating cyclins E and A
equally.An alternative possibility is that cyclin A-Cdk complexes play
an essential, nonredundant function in stem cells by phosphory-
lating stem cell-specific cellular protein(s). Since the identity of
these phosphorylation targets is currently unknown, one cannot
test this hypothesis by biochemical means. However, this possi-
bility can be verified genetically by creating a knockin mouse
strain in which cyclin A2 coding sequences would be replaced
by those of cyclin E, and by assessing the ability of knockin cyclin
E to drive proliferation of cyclin A-dependent compartments
(such as hematopoietic stem cells).
It also remains to be seen whether the function of cyclin A in
stem cell compartments is kinase dependent. Currently, the
best-documented function of cyclin proteins is their ability to acti-
vate cyclin-dependent kinases (Sherr andRoberts, 2004). Hence,
it seems likely that the function of cyclin A in vivo is mediated by
cyclin A-Cdk1 and A-Cdk2 kinases. However, cyclin D-Cdk4
and D-Cdk6 complexes were shown to play kinase-independent
functions during cell-cycle progression (Sherr and Roberts,
2004). Moreover, cyclin E was recently found to play a kinase-
independent function in cell-cycle re-entry from quiescence
(Geng et al., 2007). Creation of knockin mice expressing kinase-
inactive mutant versions of cyclin A would allow one to query
thecontributionof kinase-dependent and -independent functions
of cyclin A to proliferation of cyclin A-dependent compartments.
It is surprising that altered levels of several cell-cycle proteins
selectively affected proliferation of stem cells. For example, defi-
ciency in the polycomb family transcriptional repressor Bmi-1
caused increased levels of p16INK4a—an inhibitor of cyclin
D-Cdk kinase—and led to greatly reduced self-renewal of neural
stem cells and hematopoietic stem cells (Molofsky et al., 2003;
Park et al., 2003). Consistent with these findings, it was shown
that increased p16INK4a levels during aging contribute to age-
dependent decline in regenerative capacity of pancreatic islet
cells, neural stem cells, and hematopoietic stem cells, while
ablation of p16INK4a reversed these changes (Janzen et al.,
2006; Krishnamurthy et al., 2006; Molofsky et al., 2006). More-
over, mice lacking all three D-type cyclins died due to an anemia
caused by a proliferative failure of embryonic hematopoietic
stem cells, while proliferation of the majority of other cell types
proceeded unperturbed in the absence of D cyclins (Kozar
et al., 2004). Collectively, these observations suggest that wiring
of cell-cycle pathways in stem cells may operate in a more rigid
and nonredundant fashion than it does in other cell types. This
mechanism may allow stem cells to selectively respond to envi-
ronmental cues by specifically upregulating a particular compo-
nent of the cell-cycle engine, and to undergo self-renewal, asym-
metric division, or cell differentiation.
It remains to be seen whether this strict requirement for partic-
ular cell-cycle proteins also operates in cancer stem cells. If it
does, a therapy targeting cyclin proteins might be highly selec-
tive in shutting off the proliferation of these cells within(D) Single-colony PCR of colonies derived from ESCs electroporated with Cre.
(E) Upper panel: western blot analysis of wild-type fibroblasts (MEF) and bone marrow cells (BM) probed with the indicated antibodies. Lower panel: Cdk2 was
immunoprecipitated (IP), followed by immunoblotting with the indicated antibodies.
(F) Cdk1 or Cdk2 were immunoprecipitated from wild-type MEFs or bone marrow cells (BM) and subjected to in vitro kinase reactions, with histone H1 used as
a substrate.
(G) Same analysis as in (E) with fibroblasts and ESCs.Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc. 363
a developing tumor. Cyclin A2-overexpression was shown to
endow cells with anchorage-independent growth (Barrett et al.,
1995; Guadagno et al., 1993; Yang and Krauss, 1997); therefore,
blocking cyclin A2 functionmay revert an important step in onco-
genic transformation. Also, the Myc oncogene has been postu-
lated to signal by upregulating cyclin A (Barrett et al., 1995; Jan-
sen-Durr et al., 1993; Qi et al., 2007), hence Myc-overexpressing
human cancers might represent good candidates for anti-cyclin
A therapy.
In the opposite setting, transiently stimulating the expression
levels of particular cyclins, such as A or D cyclins, might increase
the proliferative potential of normal stem cells, thereby augment-
ing tissue regeneration after an injury or relieving age-related
functional changes in the stem cell compartment.
Indeed, overexpression of cyclin A2 in transgenic mice was
shown to improve cardiac regeneration after myocardial infarc-
tion by augmenting the proliferative capacity of cardiac progen-
itor cells (Cheng et al., 2007). Therefore, elucidation of themolec-
ular functions of cell-cycle regulators in different stem cell
populations may have far reaching implications for treatments
of various disease states.
EXPERIMENTAL PROCEDURES
Generation of Conditional cyclin A2f/f Mice
Generation of cyclin A2 gene targeting construct, conditional cyclin A2
knockout ESCs, and mice is described in the Supplemental Experimental
Procedures. Genotyping of cyclin A2 knockout mice was performed with
primers p1 (50-CGC AGC AGA AGC TCA AGA CTC GAC-30), p2 (50-TCT ACA
TCC TAA TGC AAT GCC TGG-30), and p4 (50-CAC TCA CAC ACT TAG TGT
CTC TGG-30) by denaturation of the DNA at 94C for 3 min, followed by
30 cycles of amplification: 94C for 1 min, 64C for 1 min, 72C for 1 min,
and a final extension step at 72C for 7min. Thewild-type cyclin A2 allele yields
a 335 bp product, cyclin A2f a 392 bp product, and cyclin A2D a 580 bp
product.
Tetraploid Complementation, Derivation, and Analyses
of Fibroblasts
cyclin E1/E2/A1/A2f/f ESCs were derived from blastocyst-stage
embryos, cultured, and injected into tetraploid blastocysts as described
(Geng et al., 2003). Fibroblastswere derived fromembryos at day 13.5 of gesta-
tion, cultured, pulsedwith BrdU and [3H]-thymidine, and analyzed as described
(Geng et al., 2003) (see the Supplemental Experimental Procedures).
For transduction of cyclin A2f/f or A1/A2f/f fibroblasts with Cre, we used
the hit-and-run system-based retroviruses expressing wild-type Cre, or, as
a control, an enzymatically inactive Cre point mutant (Silver and Livingston,
2001). Production of viral supernatants and infection of cells was performed
as described (Silver and Livingston, 2001). Fibroblasts were infected twice
for 4 hr, with a 24 hr interval between infections, using 10MOI of virus. For anal-
yses of cyclin A1/A2f/fE1/E2/ fibroblasts, cells were infected twice, as
above with 50 MOI of Adeno-Cre (from Vector Development Lab, Baylor
College of Medicine) or the same amount of virus carrying an empty vector.
Assays were performed after 48–72 hr.
Western Blotting
This was performed as described in the Supplemental Experimental Proce-
dures with antibodies against cyclin A2 (sc-596 from Santa Cruz, or c4710
from Sigma), D2, D3, Cdk2, Cdk6 (all from Santa Cruz), cyclin D1, Cdk4,
Cdk1 (all from NeoMarkers), cyclin B1 (Sigma), p27 (BD Bioscience), actin
(Chemicon), or cyclin E1 (kindly provided by Dr. B. Clurman). Densitometric
analyses of band intensities were performed with ImageJ software (http://
rsb.info.nih.gov/ij/index.html).364 Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc.Hematopoietic Analyses
Eight- to ten-week-old cyclin A2f/f MxCre, A1/A2f/f MxCre, or control A1+/
A2f/+ MxCre mice were injected five times, every other day, with 400 mg of
polyinosinic-polycytidylic acid (pI-pC, Sigma). Peripheral blood analyses
were performed with MASCOT Hemavet 850 counter (CDC Technologies).
Staining and flow cytometry of bone marrow cells, as well as methylcellulose
cultures, was performed as described (Kozar et al., 2004).
Analyses of Hematopoietic Stem Cells and Progenitors
Bone marrow cells were collected from cyclin A1/A2f/f MxCre, A2f/f MxCre,
and control A1+/A2f/+ MxCremice 7 days after the last pI-pC dose. HSCs and
lineage-committed progenitors were stained and analyzed essentially as
described (Akashi et al., 2000) (see the Supplemental Experimental Proce-
dures). cyclin A2 deletion in purified HSCs was performed as described in
the Supplemental Experimental Procedures.
Analyses of ESCs
cyclin A1/A2f/f and control A1+/A2f/+ ESCs were derived from blastocyst-
stage embryos as described (Geng et al., 2003). Two hundred thousand
ESCs were transduced with hit-and-run retrovirus (Silver and Livingston,
2001), and plated at 5 3 103 cells per 10 cm plate with feeders. Colonies
were evaluated after 8–12 days.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and five
figures and can be found with this article online at http://www.cell.com/
supplemental/S0092-8674(09)00527-3.
ACKNOWLEDGMENTS
We thank members of the Sicinski lab, R. Bronson, E. Sicinska, M.A. Ciemer-
ych-Litwinienko, A. Minamishima, S. Kobayashi, and B. Will for help and
advice, B. Clurman for anti-cyclin E1 antibody, and F. Liu for anti-phospho
Smad3 antibodies. This work was supported by R01CA132740 and
R01CA108950 grants from the National Institutes of Health (to P.S.) and R01
HD34915 (to D.J.W.). P.S. is a Scholar of The Leukemia and Lymphoma
Society.
Received: November 24, 2008
Revised: March 15, 2009
Accepted: April 29, 2009
Published online: July 9, 2009
REFERENCES
Akashi, K., Traver, D., Miyamoto, T., and Weissman, I.L. (2000). A clonogenic
commonmyeloid progenitor that gives rise to all myeloid lineages. Nature 404,
193–197.
Barrett, J.F., Lewis, B.C., Hoang, A.T., Alvarez, R.J., Jr., and Dang, C.V. (1995).
Cyclin A links c-Myc to adhesion-independent cell proliferation. J. Biol. Chem.
270, 15923–15925.
Cheng, R.K., Asai, T., Tang, H., Dashoush, N.H., Kara, R.J., Costa, K.D., Naka,
Y., Wu, E.X., Wolgemuth, D.J., and Chaudhry, H.W. (2007). Cyclin A2 induces
cardiac regeneration after myocardial infarction and prevents heart failure.
Circ. Res. 100, 1741–1748.
den Elzen, N., and Pines, J. (2001). Cyclin A is destroyed in prometaphase and
can delay chromosome alignment and anaphase. J. Cell Biol. 153, 121–136.
Eggan, K., Akutsu, H., Loring, J., Jackson-Grusby, L., Klemm, M., Rideout,
W.M., 3rd, Yanagimachi, R., and Jaenisch, R. (2001). Hybrid vigor, fetal over-
growth, and viability of mice derived by nuclear cloning and tetraploid embryo
complementation. Proc. Natl. Acad. Sci. USA 98, 6209–6214.
Erlandsson, F., Linnman, C., Ekholm, S., Bengtsson, E., and Zetterberg, A.
(2000). A detailed analysis of cyclin A accumulation at the G(1)/S border in
normal and transformed cells. Exp. Cell Res. 259, 86–95.
Evans, T., Rosenthal, E.T., Youngblom, J., Distel, D., and Hunt, T. (1983).
Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is
destroyed at each cleavage division. Cell 33, 389–396.
Furuno, N., den Elzen, N., and Pines, J. (1999). Human cyclin A is required for
mitosis until mid prophase. J. Cell Biol. 147, 295–306.
Geley, S., Kramer, E., Gieffers, C., Gannon, J., Peters, J.M., and Hunt, T.
(2001). Anaphase-promoting complex/cyclosome-dependent proteolysis of
human cyclin A starts at the beginning of mitosis and is not subject to the
spindle assembly checkpoint. J. Cell Biol. 153, 137–148.
Geng, Y., Yu, Q., Sicinska, E., Das, M., Schneider, J.E., Bhattacharya, S.,
Rideout, W.M., Bronson, R.T., Gardner, H., and Sicinski, P. (2003). Cyclin E
ablation in the mouse. Cell 114, 431–443.
Geng, Y., Lee, Y.M., Welcker, M., Swanger, J., Zagozdzon, A., Winer, J.D.,
Roberts, J.M., Kaldis, P., Clurman, B.E., and Sicinski, P. (2007). Kinase-inde-
pendent function of cyclin E. Mol. Cell 25, 127–139.
Girard, F., Strausfeld, U., Fernandez, A., and Lamb, N.J. (1991). Cyclin A is
required for the onset of DNA replication in mammalian fibroblasts. Cell 67,
1169–1179.
Gong, D., Pomerening, J.R., Myers, J.W., Gustavsson, C., Jones, J.T., Hahn,
A.T.,Meyer, T., and Ferrell, J.E., Jr. (2007). Cyclin A2 regulates nuclear-envelope
breakdown and the nuclear accumulation of cyclin B1. Curr. Biol. 17, 85–91.
Guadagno, T.M., Ohtsubo, M., Roberts, J.M., and Assoian, R.K. (1993). A link
between cyclin A expression and adhesion-dependent cell cycle progression.
Science 262, 1572–1575.
Hochegger, H., Takeda, S., and Hunt, T. (2008). Cyclin-dependent kinases and
cell-cycle transitions: does one fit all? Nat. Rev. Mol. Cell Biol. 9, 910–916.
Jansen-Durr, P., Meichle, A., Steiner, P., Pagano, M., Finke, K., Botz, J., Wess-
becher, J., Draetta, G., and Eilers, M. (1993). Differential modulation of cyclin
gene expression by MYC. Proc. Natl. Acad. Sci. USA 90, 3685–3689.
Janzen, V., Forkert, R., Fleming, H.E., Saito, Y., Waring, M.T., Dombkowski,
D.M., Cheng, T., DePinho, R.A., Sharpless, N.E., and Scadden, D.T. (2006).
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor
p16INK4a. Nature 443, 421–426.
Ji, P., Agrawal, S., Diederichs, S., Ba¨umer, N., Becker, A., Cauvet, T., Kowski,
S., Beger, C., Welte, K., Berdel, W.E., et al. (2005). Cyclin A1, the alternative
A-type cyclin, contributes to G1/S cell cycle progression in somatic cells.
Oncogene 24, 2739–2744.
Kozar,K.,Ciemerych,M.A.,Rebel, V.I., Shigematsu,H., Zagozdzon,A., Sicinska,
E., Geng, Y., Yu, Q., Bhattacharya, S., Bronson, R.T., et al. (2004). Mouse devel-
opment and cell proliferation in the absence of D-cyclins. Cell 118, 477–491.
Krishnamurthy, J., Ramsey, M.R., Ligon, K.L., Torrice, C., Koh, A., Bonner-
Weir, S., and Sharpless, N.E. (2006). p16INK4a induces an age-dependent
decline in islet regenerative potential. Nature 443, 453–457.
Kuhn, R., Schwenk, F., Aguet, M., and Rajewsky, K. (1995). Inducible gene
targeting in mice. Science 269, 1427–1429.
Lehner, C.F., and O’Farrell, P.H. (1989). Expression and function of Drosophila
cyclin A during embryonic cell cycle progression. Cell 56, 957–968.
Lehner, C.F., andO’Farrell, P.H. (1990). The roles of Drosophila cyclins A andB
in mitotic control. Cell 61, 535–547.
Li, W., Kotoshiba, S., and Kaldis, P. (2009). Genetic mouse models to investi-
gate cell cycle regulation. Transgenic Res., in press. Published online May 9,
2009. 10.1007/s11248-009-9276-x.
Liu,D.,Matzuk,M.M.,Sung,W.K.,Guo,Q.,Wang,P., andWolgemuth,D.J. (1998).
Cyclin A1 is required for meiosis in the male mouse. Nat. Genet. 20, 377–380.
Malumbres, M., and Barbacid, M. (2009). Cell cycle, CDKs and cancer: a
changing paradigm. Nat. Rev. Cancer 9, 153–166.
Molofsky, A.V., Pardal, R., Iwashita, T., Park, I.K., Clarke, M.F., and Morrison,
S.J. (2003). Bmi-1 dependence distinguishes neural stem cell self-renewal
from progenitor proliferation. Nature 425, 962–967.Molofsky, A.V., Slutsky, S.G., Joseph, N.M., He, S., Pardal, R., Krishnamurthy,
J., Sharpless, N.E., andMorrison, S.J. (2006). Increasing p16INK4a expression
decreases forebrain progenitors and neurogenesis during ageing. Nature 443,
448–452.
Morrison, S.J., Hemmati, H.D., Wandycz, A.M., andWeissman, I.L. (1995). The
purification and characterization of fetal liver hematopoietic stem cells. Proc.
Natl. Acad. Sci. USA 92, 10302–10306.
Murphy, M., Stinnakre, M.G., Senamaud-Beaufort, C., Winston, N.J., Swee-
ney, C., Kubelka, M., Carrington, M., Brechot, C., and Sobczak-Thepot, J.
(1997). Delayed early embryonic lethality following disruption of the murine
cyclin A2 gene. Nat. Genet. 15, 83–86.
Nieduszynski, C.A., Murray, J., and Carrington, M. (2002). Whole-genome
analysis of animal A- and B-type cyclins. Genome Biol. 3, RESEARCH0070.
Nusse, R. (2008). Wnt signaling and stem cell control. Cell Res. 18, 523–527.
Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., and Draetta, G. (1992).
Cyclin A is required at two points in the human cell cycle. EMBOJ. 11, 961–971.
Parisi, T., Beck, A.R., Rougier, N., McNeil, T., Lucian, L., Werb, Z., and Amati,
B. (2003). Cyclins E1 and E2 are required for endoreplication in placental
trophoblast giant cells. EMBO J. 22, 4794–4803.
Park, I.K., Qian, D., Kiel, M., Becker, M.W., Pihalja, M., Weissman, I.L., Morri-
son, S.J., and Clarke, M.F. (2003). Bmi-1 is required for maintenance of adult
self-renewing haematopoietic stem cells. Nature 423, 302–305.
Pines, J., and Hunter, T. (1990). Human cyclin A is adenovirus E1A-associated
protein p60 and behaves differently from cyclin B. Nature 346, 760–763.
Qi, Y., Tu, Y., Yang, D., Chen, Q., Xiao, J., Chen, Y., Fu, J., Xiao, X., and Zhou,
Z. (2007). Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-
cycle progression. J. Cell. Physiol. 210, 63–71.
Sherr, C.J., and Roberts, J.M. (2004). Living with or without cyclins and cyclin-
dependent kinases. Genes Dev. 18, 2699–2711.
Silver, D.P., and Livingston, D.M. (2001). Self-excising retroviral vectors
encoding the Cre recombinase overcome Cre-mediated cellular toxicity.
Mol. Cell 8, 233–243.
Sweeney, C., Murphy, M., Kubelka, M., Ravnik, S.E., Hawkins, C.F., Wolge-
muth, D.J., and Carrington, M. (1996). A distinct cyclin A is expressed in
germ cells in the mouse. Development 122, 53–64.
Swenson, K.I., Farrell, K.M., and Ruderman, J.V. (1986). The clam embryo
protein cyclin A induces entry into M phase and the resumption of meiosis in
Xenopus oocytes. Cell 47, 861–870.
Tallquist, M.D., and Soriano, P. (2000). Epiblast-restricted Cre expression in
MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene
function. Genesis 26, 113–115.
van der Meer, T., Chan, W.Y., Palazon, L.S., Nieduszynski, C., Murphy, M.,
Sobczak-Thepot, J., Carrington, M., and Colledge, W.H. (2004). Cyclin A1
protein shows haplo-insufficiency for normal fertility in male mice. Reproduc-
tion 127, 503–511.
Welm, A.L., Timchenko, N.A., Ono, Y., Sorimachi, H., Radomska, H.S., Tenen,
D.G., Lekstrom-Himes, J., and Darlington, G.J. (2002). C/EBPalpha is required
for proteolytic cleavage of cyclin A by calpain 3 in myeloid precursor cells.
J. Biol. Chem. 277, 33848–33856.
Yam, C.H., Fung, T.K., and Poon, R.Y. (2002). Cyclin A in cell cycle control and
cancer. Cell. Mol. Life Sci. 59, 1317–1326.
Yang, J.J., and Krauss, R.S. (1997). Extracellular ATP induces anchorage-
independent expression of cyclin A and rescues the transformed phenotype
of a ras-resistant mutant cell line. J. Biol. Chem. 272, 3103–3108.
Yang, R., Morosetti, R., and Koeffler, H.P. (1997). Characterization of a second
human cyclin A that is highly expressed in testis and in several leukemic cell
lines. Cancer Res. 57, 913–920.
Zindy, F., Lamas, E., Chenivesse, X., Sobczak, J., Wang, J., Fesquet, D., Hen-
glein, B., and Brechot, C. (1992). Cyclin A is required in S phase in normal
epithelial cells. Biochem. Biophys. Res. Commun. 182, 1144–1154.Cell 138, 352–365, July 24, 2009 ª2009 Elsevier Inc. 365
